Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: DrugBank:EXPT01586 (
G418
)
2,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Connective tissue growth factor
(
CTGF
) is involved in the differentiation of lung fibroblast into myofibroblast and is considered as an important mediator in the pathogenesis of pulmonary fibrosis. In the present study, a
CTGF
small interference RNA (siRNA) expressing plasmid (
CTGF
-siRNA) was constructed and stably transfected into human lung fibroblast cell line, MRC-5. Stable clones with
CTGF
gene silencing (
CTGF
-siRNA/MRC-5) were successfully established by
G418
screening and further confirmed by real-time quantitative PCR and Western blot. Cell proliferation was investigated by growth curve analysis, and cell doubling time of the
CTGF
-siRNA/MRC-5 cells was markedly longer than that of the control cells (P < 0.05). Compared with control cells, the expression of alpha-smooth muscle actin (alpha-SMA), the marker of myofibroblast differentiation, was decreased in
CTGF
-siRNA/MRC-5 cells. Moreover, the deposition of extracellular matrix (ECM) proteins (such as collagen type I and fibronectin) in
CTGF
-siRNA/MRC-5 cells was also declined. Our data suggest that
CTGF
may play an important role in the differentiation of lung fibroblast into myofibroblast, and that siRNA targeting
CTGF
gene might provide a new strategy for gene therapy of pulmonary fibrosis.
...
PMID:[Effects of CTGF gene silencing on the proliferation and myofibroblast differentiation of human lung fibroblasts]. 1861 Jun 32